Why Did AIFF Stock Surge Over 20% Pre-Market Today?

The company will deploy its AI-powered EEG/ERP system to assess and treat brain injuries in service members and veterans.
Firefly Neuroscience’s stock has risen 2.3% so far in 2025. (Photo credit: Getty Images)
Firefly Neuroscience’s stock has risen 2.3% so far in 2025. (Photo credit: Getty Images)
Profile Image
Shivani Kumaresan·Stocktwits
Published Mar 26, 2026   |   8:07 AM EDT
Share
·
Add us onAdd us on Google

Firefly Neuroscience Inc. (AIFF) announced on Thursday an agreement with the Department of War to deploy its artificial intelligence-driven EEG/ERP platform for evaluating and treating active-duty personnel and veterans affected by PTSD and traumatic brain injuries.

The initiative focuses on using advanced brain-monitoring technology to address persistent challenges tied to military health.

The effort builds on earlier research conducted with a U.S. Naval Medical Center program, laying the groundwork for broader adoption across military healthcare systems.

Following the update, Firefly Neuroscience stock traded over 20% in Thursday’s premarket. 

Get updates to this developing story directly on Stocktwits.

Follow on Google News
Read about our editorial guidelines and ethics policy